GLOFITAMAB

Clinical trials for GLOFITAMAB explained in plain language.

Never miss a new study

Get alerted when new GLOFITAMAB trials appear

Sign up with your email to follow new studies for GLOFITAMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for aggressive lymphoma: targeted combo aims to keep cancer in check

Disease control Recruiting now

This study tests whether giving the drug glofitamab after an initial treatment with BTKi and rituximab can better control high-risk mantle cell lymphoma (MCL) that has not been treated before. About 30 adults with newly diagnosed, high-risk MCL will receive this two-step approach…

Matched conditions: GLOFITAMAB

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 15, 2026 11:55 UTC

GLOFITAMAB

Get alerted when new GLOFITAMAB trials appear

New hope for aggressive lymphoma: targeted combo aims to keep cancer in check